Related Experiment Video
Updated: Jul 8, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
[Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma
Chen Huang1, Jia-yi Yao, Zong-fang Li
1Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Xi'an Jiaotong University College of Medicine, Xi'an 710061, China.
Objective:
To study the mechanism of hepatic carcinoma cell apoptosis induced by small interfering RNA (siRNA)-mediated nuclear factor-kappaB (NF-kappaB) P65 silencing.
Methods:
Hepatic carcinoma SMMC-7721 cells were exposed to liposome-mediated transfection with NF-kappaB P65 siRNA synthesized by in vitro transcription, and the cells with empty liposome transfection and those without particular treatment served as the control groups. The expression of NF-kappaB P65 in the cells was detected by Western blotting, the cell viability examined by MTT assay, and the cell apoptosis assessed by flow cytometry. Immunohistochemistry was used to examine the expressions of Bcl-2 and Bax.
Results:
siRNA transfection significantly inhibited the expression of NF-kappaB P65 in SMMC-7721cells, with inhibition rates of 64.74% compared with the untreated cells and of 34.52% compared with the liposome-treated cells. The siRNA-treated SMMC-7721 cells also exhibited significant decrease in cell proliferation by 33.39% and 27.23% in comparison with the untreated and liposome-treated cells, respectively. NF-kappaB P65 siRNA induced obvious cell apoptosis with down-regulated Bcl-2 and up-regulated Bax expressions.
Conclusion:
NF-kappaB p65 siRNA can induce SMMC-7721 cell apoptosis via the Bcl-2/Bax pathway.
Insights
Small interfering RNA (siRNA) targeting nuclear factor-kappaB (NF-kappaB) P65 effectively induces hepatic carcinoma cell apoptosis. This occurs through the Bcl-2/Bax pathway, offering a potential therapeutic strategy for liver cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Context:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited effective treatments.
- Nuclear factor-kappaB (NF-kappaB) signaling pathways are frequently dysregulated in various cancers, including HCC, promoting cell survival and proliferation.
- Targeting key regulatory molecules within these pathways presents a promising avenue for novel cancer therapies.
Purpose:
- To investigate the mechanism by which small interfering RNA (siRNA)-mediated silencing of the NF-kappaB P65 subunit induces apoptosis in hepatic carcinoma cells.
- To evaluate the effects of NF-kappaB P65 siRNA on SMMC-7721 cell viability, proliferation, and apoptosis.
- To elucidate the role of Bcl-2 and Bax protein expression in NF-kappaB P65 siRNA-induced apoptosis.
Summary:
- Liposome-mediated transfection with NF-kappaB P65 siRNA significantly reduced NF-kappaB P65 expression in SMMC-7721 cells.
- siRNA treatment led to a marked decrease in cell proliferation and induced significant apoptosis.
- NF-kappaB P65 silencing resulted in downregulation of the anti-apoptotic protein Bcl-2 and upregulation of the pro-apoptotic protein Bax.
Impact:
- This study demonstrates that NF-kappaB P65 siRNA can effectively induce apoptosis in hepatic carcinoma cells.
- The findings suggest that the Bcl-2/Bax pathway is critically involved in mediating NF-kappaB P65 siRNA-induced cell death.
- Targeting NF-kappaB P65 with siRNA represents a potential therapeutic strategy for hepatocellular carcinoma.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting